MAT, MATE, OUD and OBOT: Implementing an Effective Addiction Medicine Curriculum for Internal Medic

When:  Jan 21, 2025 from 02:00 PM to 03:00 PM (ET)

In 2022, the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts were signed into law. These laws are intended to expand access to buprenorphine for the treatment of opioid use disorder (OUD) and to normalize and enhance substance use care across healthcare settings. The MAT act removes federal barriers to prescribing buprenorphine for OUD and the MATE Act requires new or renewing DEA registrants to have eight hours of training on opioid and other substance use disorders (SUD). Completion of a SUD curriculum of at least 8 hours during residency fulfills this requirement. The curriculum must include the treatment and management of patients with opioid and other SUD. With these changes, and a 2022 ACGME requirement for internal medicine programs to expand addiction medicine education, there continues to be a need to develop effective  SUD curricula.  In this webinar, presenters discuss an innovative curriculum for teaching internal medicine residents best practices in chronic pain management, safe opioid prescribing, recognition and treatment of OUD, office-based opioid treatment, recognition and treatment of alcohol and tobacco use disorders, and harm reduction.  Faculty will discuss their experiences implementing this curriculum; provide educational tools including a competency-based evaluation and feedback instrument used for ambulatory observations or OSCEs, and discuss obtaining hands-on clinical experiences for residents. Participants will have the opportunity to engage in group discussion and to discuss implementation strategies enabling them to leave the workshop with experience using the competency-based tool and concrete ideas to develop their own residency curriculum.

Presenters:
Therese Vettese, MD
Eva Rimler, MD
Shelly-Ann Fluker, MD

REGISTER TODAY

Location